• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION THE Q-TRAK SUBCUTANEOUS ELECTRODE; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION THE Q-TRAK SUBCUTANEOUS ELECTRODE; IMPLANTABLE LEAD Back to Search Results
Model Number 3010
Device Problems Signal Artifact/Noise (1036); High impedance (1291); Device Sensing Problem (2917); Device Contamination with Chemical or Other Material (2944)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/18/2013
Event Type  Injury  
Event Description
It was reported that an alert was generated for this system due to a high shocking impedance measurement.A boston scientific technical services consultant reviewed the device data and identified the shocking impedance had been exhibiting a gradual increase since implant.There was a single atrial fibrillation (af) event with some noise, the consultant recommended troubleshooting and obtaining an x-ray to assess for anything grossly wrong with the electrode.A revision procedure was performed and poor sensing was noted in all vectors.Tissue encapsulation in the electrode end was suspected.The electrode was explanted and replaced.The associated subcutaneous implantable cardioverter defibrillator (s-icd) was also explanted and replaced.No additional adverse patient effects were reported.
 
Manufacturer Narrative
This product is being evaluated in our post market quality assurance laboratory.This report will be updated when evaluation is complete.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, visual examination of the lead noted residue calcification on the shocking coil.Resistance and pressure tests were completed to assess electrical performance and inner insulation integrity.Measurements throughout these tests were within normal limits.Analysis determined that the impedance measurements may have been impacted by the calcification of body fluids on the shocking coil.Calcification, the process in which layers of calcium build up on a surface (e.G., leads), is a patient condition that develops over time in some populations.The mechanism of calcification is assumed to be associated with cell devitalization and accumulation of cellular debris following implantation.Past experience has shown that as calcified material builds up on the electrode surfaces of a lead, impedance measurements increase.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
It was reported that an alert was generated for this system due to a high shocking impedance measurement.A boston scientific technical services consultant reviewed the device data and identified the shocking impedance had been exhibiting a gradual increase since implant.There was a single atrial fibrillation (af) event with some noise, the consultant recommended troubleshooting and obtaining an x-ray to assess for anything grossly wrong with the electrode.A revision procedure was performed, and poor sensing was noted in all vectors.Tissue encapsulation in the electrode end was suspected.The electrode was explanted and replaced.The associated subcutaneous implantable cardioverter defibrillator (s-icd) was also explanted and replaced.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THE Q-TRAK SUBCUTANEOUS ELECTRODE
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC
4100 hamline avenue north
st. paul MN 55112
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key14709546
MDR Text Key294126478
Report Number2124215-2022-21597
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110042/S000
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/01/2015
Device Model Number3010
Device Catalogue Number3010
Device Lot NumberA106272
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/02/2022
Initial Date FDA Received06/15/2022
Supplement Dates Manufacturer Received12/21/2022
Supplement Dates FDA Received12/26/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age71 YR
Patient SexMale
-
-